Clinical staging for prostate cancer is often inaccurate, especially for T2 cases which frequently progress to pT3. Pathological stage significantly impacts recurrence risk and lymph node involvement, highlighting the need for accurate staging in radical prostatectomy patients.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: